Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 04-02-2015 | Practice Area: | Equity Capital Markets | ||||||||
| Deal Title: | Oxford Immunotec Global PLC Registered Share Offering | Industry: | Pharmaceuticals & Biotechnology | ||||||||
| Description: |
Davis Polk advised J.P. Morgan Securities LLC and Piper Jaffray and Co. as representatives of the several underwriters in connection with the USD54 million SEC-registered offering of 4,893,616 ordinary shares of Oxford Immunotec Global PLC, including 638,297 shares from the exercise of the underwriters' option. The ordinary shares are listed on The NASDAQ Global Market under the symbol OXFD.
The Davis Polk corporate team included partner Deanna L. Kirkpatrick and associates Melissa Glass, Felipe Duque and Christopher M. Bezeg. Associate Dan Hirschovits advised on certain English corporate law matters. Partner Harry Ballan and associate Joseph Pahl advised on U.S. tax matters, and partner Jonathan Cooklin and associate Dominic Foulkes advised on certain English tax law matters. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the New York and London offices.
|
||||||||||
| Financial Center: | New York | Value: | 0.00-100.00 | ||||||||
| Advised Party: | Underwriter | Law Firm | Davis Polk | ||||||||
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States | ||||||||
| Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Deanna L Kirkpatrick | ||||||||
| Further Information: |
|
||||||||||
View PDF
